ArticleFrontiers in aging2026
Evaluating the performance of large language models in sarcopenia-related patient queries: a foundational assessment for patient-centered validation.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From Molecular Pathways to Artificial Intelligence: Advancing the Understanding and Management of Osteosarcopenia.International journal of molecular sciences · 2026Review
- Emerging era of robotics and artificial intelligence in orthopaedic trauma surgery.Journal of orthopaedic translation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Large Language Models (LLMs) have shown promise in clinical applications but their performance in specialized areas such as sarcopenia remains understudied. Methods: A panel of sarcopenia clinician researchers developed 20 standardized patient-centered questions across six clinical domains. Each question was input into all three LLMs, and responses were anonymized, randomized, and independently assessed by three clinician researchers. Accuracy was graded on a four-point scale ("Poor" to "Excellent"), and comprehensiveness was evaluated for responses rated "Good" or higher using a five-point scale. Results: All LLMs achieved good performance, with no responses rated "Poor" across any domain. Deepseek had the longest and most detailed responses (mean word count: 583.75 ± 71.89) and showed superior performance in "risk factors" and "prognosis." ChatGPT provided the most concise replies (359.5 ± 87.89 words, p = 0.0011) but achieved the highest proportion of "Good" ratings (90%). Gemini excelled in "pathogenesis" and "diagnosis" but received the most critical feedback in "prevention and treatment." Although trends in performance differences were noted, they did not reach statistical significance. Mean comprehensiveness scores were also similar across models (Deepseek: 4.017 ± 0.77, Gemini: 3.97 ± 0.88, ChatGPT: 3.953 ± 0.83; p > 0.05). Conclusion: Despite minor differences in performance across domains, all three LLMs demonstrated acceptable accuracy and comprehensiveness when responding to sarcopenia-related queries. Their comparable results may reflect similarly recent training data and language capabilities. These findings suggest that LLMs could potentially serve as a valuable tool in patient education and care on sarcopenia. This study provides an initial, expert-based assessment of LLM information quality regarding sarcopenia. While the responses demonstrated good accuracy, this evaluation focuses on content correctness from a clinical perspective. Future research must complement these findings by directly engaging older adult cohorts before clinical implementation can be considered. However, human oversight remains essential to ensure safe and appropriate assessment and individually tailored advice and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.